MENU
+Compare
TRIB
Stock ticker: NASDAQ
AS OF
Jan 22 closing price
Price
$0.77
Change
-$0.04 (-4.94%)
Capitalization
14.9M

TRIB Trinity Biotech plc Forecast, Technical & Fundamental Analysis

a devloper of medical diagnostic products

TRIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for TRIB with price predictions
Jan 08, 2025

TRIB saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for TRIB moved out of overbought territory on January 08, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 42 similar instances where the indicator exited the overbought zone. In of the 42 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TRIB as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRIB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TRIB broke above its upper Bollinger Band on January 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.112) is normal, around the industry mean (23.424). P/E Ratio (33.003) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.329) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.209) is also within normal values, averaging (41.167).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TRIB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRIB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
TRIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TRIB is expected to report earnings to fall 20.00% to -69 cents per share on March 07

Trinity Biotech plc TRIB Stock Earnings Reports
Q4'23
Est.
$-0.70
Q3'23
Missed
by $0.73
Q2'23
Missed
by $0.07
Q1'23
Missed
by $0.77
Q4'22
Missed
by $0.21
The last earnings report on January 31 showed earnings per share of -87 cents, missing the estimate of -15 cents. With 86.63K shares outstanding, the current market capitalization sits at 14.90M.
A.I.Advisor
published Dividends

TRIB paid dividends on July 01, 2015

Trinity Biotech plc TRIB Stock Dividends
А dividend of $0.22 per share was paid with a record date of July 01, 2015, and an ex-dividend date of June 05, 2015. Read more...
A.I. Advisor
published General Information

General Information

a devloper of medical diagnostic products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
IDA Business Park
Phone
+353 12769800
Employees
398
Web
https://www.trinitybiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGNX3.080.08
+2.67%
MacroGenics
SLRC16.73-0.10
-0.59%
SLR Investment Corp
BBY83.92-0.61
-0.72%
Best Buy Company
HASI27.05-0.50
-1.81%
HA Sustainable Infrastructure Capital Inc.
VRME2.40-0.60
-20.00%
VerifyMe

TRIB and Stocks

Correlation & Price change

A.I.dvisor tells us that TRIB and NVRO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRIB and NVRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRIB
1D Price
Change %
TRIB100%
-4.01%
NVRO - TRIB
31%
Poorly correlated
+4.70%
RGEN - TRIB
28%
Poorly correlated
-0.64%
NVCR - TRIB
26%
Poorly correlated
-0.50%
SERA - TRIB
23%
Poorly correlated
-1.81%
COO - TRIB
23%
Poorly correlated
-0.18%
More